[1]
P. Nurzyński and A. Deptała, “Everolimus in clinical practice. Review of German non-interventional study of everolimus in metastatic renal cell cancer after failure of initial tyrosine kinase inhibitor therapy”, OncoReview, vol. 3, no. 3(11), pp. 208-212, Oct. 2013.